Juhani Knuuti
@juhaniknuuti.bsky.social
Professor of Cardiovascular imaging at Faculty of Medicine, University of Turku and director of Turku PET Centre, Turku, Finland. My major hobby is to popularise science and playing saxophone (but not at the same time ;-) ).
Our paper was rejected from journal because it included subjects of only single-sex/gender.
Fine as such. But the study utilized EXPERIMENTAL MYOCARDIAL INFARCTION IN MALE RATS.
Next time we need to ask the rats whether they feel female or male to fulfill these requirements.
Fine as such. But the study utilized EXPERIMENTAL MYOCARDIAL INFARCTION IN MALE RATS.
Next time we need to ask the rats whether they feel female or male to fulfill these requirements.
January 24, 2025 at 10:36 AM
Our paper was rejected from journal because it included subjects of only single-sex/gender.
Fine as such. But the study utilized EXPERIMENTAL MYOCARDIAL INFARCTION IN MALE RATS.
Next time we need to ask the rats whether they feel female or male to fulfill these requirements.
Fine as such. But the study utilized EXPERIMENTAL MYOCARDIAL INFARCTION IN MALE RATS.
Next time we need to ask the rats whether they feel female or male to fulfill these requirements.
Congraz to Arghavan Jahandideh for a successfully defence.
January 10, 2025 at 12:54 PM
Congraz to Arghavan Jahandideh for a successfully defence.
For the sake of US citizens, I hope that a person with this level of ignorance shall not be appointed to any responsible role in heathcare.
Both claims are 100% wrong. Evidence:
www.undermind.ai/query_app/di...
www.undermind.ai/query_app/di...
Both claims are 100% wrong. Evidence:
www.undermind.ai/query_app/di...
www.undermind.ai/query_app/di...
January 7, 2025 at 11:35 AM
For the sake of US citizens, I hope that a person with this level of ignorance shall not be appointed to any responsible role in heathcare.
Both claims are 100% wrong. Evidence:
www.undermind.ai/query_app/di...
www.undermind.ai/query_app/di...
Both claims are 100% wrong. Evidence:
www.undermind.ai/query_app/di...
www.undermind.ai/query_app/di...
A new drug, muvalaplin, is able to reduce blood Lp(a) concentrations effectively and safely. Lp(a) has been linked with high cardiocascular risk but no therapies for it.
However, pls note that we have no idea if reducing Lp(a) will provide clinical benefit.
jamanetwork.com/journals/jam...
However, pls note that we have no idea if reducing Lp(a) will provide clinical benefit.
jamanetwork.com/journals/jam...
November 20, 2024 at 6:55 AM
A new drug, muvalaplin, is able to reduce blood Lp(a) concentrations effectively and safely. Lp(a) has been linked with high cardiocascular risk but no therapies for it.
However, pls note that we have no idea if reducing Lp(a) will provide clinical benefit.
jamanetwork.com/journals/jam...
However, pls note that we have no idea if reducing Lp(a) will provide clinical benefit.
jamanetwork.com/journals/jam...
Onko kovin matalasta veren kolesterolista haittaa?
Näinhän on väitetty, kun on haluttu pelotella kolesterolia alentavien hoitojen haitoilla. Tässä mielenkiintoinen pohdinta aiheesta uteliaille. Yhteenveto kuvassa: Matala veren kolesteroli on vain eduksi.
www.medscape.com/viewarticle/...
Näinhän on väitetty, kun on haluttu pelotella kolesterolia alentavien hoitojen haitoilla. Tässä mielenkiintoinen pohdinta aiheesta uteliaille. Yhteenveto kuvassa: Matala veren kolesteroli on vain eduksi.
www.medscape.com/viewarticle/...
December 5, 2023 at 9:15 AM
Onko kovin matalasta veren kolesterolista haittaa?
Näinhän on väitetty, kun on haluttu pelotella kolesterolia alentavien hoitojen haitoilla. Tässä mielenkiintoinen pohdinta aiheesta uteliaille. Yhteenveto kuvassa: Matala veren kolesteroli on vain eduksi.
www.medscape.com/viewarticle/...
Näinhän on väitetty, kun on haluttu pelotella kolesterolia alentavien hoitojen haitoilla. Tässä mielenkiintoinen pohdinta aiheesta uteliaille. Yhteenveto kuvassa: Matala veren kolesteroli on vain eduksi.
www.medscape.com/viewarticle/...